Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 074942
Company: SANDOZ
Company: SANDOZ
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ETODOLAC | ETODOLAC | 200MG | CAPSULE;ORAL | Discontinued | None | No | No |
ETODOLAC | ETODOLAC | 300MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/30/1997 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/28/2021 | SUPPL-4 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
||
05/09/2016 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |
||
04/17/2000 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
||
10/08/1998 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |